Fidelity Investments
ANAB icon

Fidelity Investments’s AnaptysBio ANAB Stock Holding History

Fidelity Investments’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$26.2M Buy
472,704
+445,596
+1,644% +$24M ﹤0.01% 1679
2025
Q4 		$1.31M Sell
27,108
-26,054
-49% -$1.02M ﹤0.01% 2749
2025
Q3 		$1.63M Sell
53,162
-18,957
-26% -$435K ﹤0.01% 2618
2025
Q2 		$1.6M Sell
72,119
-1,833,035
-96% -$38.4M ﹤0.01% 2567
2025
Q1 		$35.4M Sell
1,905,154
-1,125,082
-37% -$18.8M ﹤0.01% 1489
2024
Q4 		$40.1M Sell
3,030,236
-278,939
-8% -$6.76M ﹤0.01% 1468
2024
Q3 		$111M Buy
3,309,175
+438,557
+15% +$15M 0.01% 1063
2024
Q2 		$71.9M Buy
2,870,618
+2,729,872
+1,940% +$63.6M ﹤0.01% 1170
2024
Q1 		$3.17M Sell
140,746
-61,965
-31% -$1.47M ﹤0.01% 2197
2023
Q4 		$4.34M Sell
202,711
-64,904
-24% -$1.12M ﹤0.01% 2106
2023
Q3 		$4.81M Sell
267,615
-25,951
-9% -$495K ﹤0.01% 2057
2023
Q2 		$5.97M Buy
293,566
+1,449
+0.5% +$29.4K ﹤0.01% 2013
2023
Q1 		$6.36M Buy
292,117
+1,201
+0.4% +$29.2K ﹤0.01% 2020
2022
Q4 		$9.02M Buy
290,916
+186,831
+179% +$5.28M ﹤0.01% 1933
2022
Q3 		$2.66M Sell
104,085
-26,807
-20% -$628K ﹤0.01% 2355
2022
Q2 		$2.66M Sell
130,892
-48,029
-27% -$1.06M ﹤0.01% 2421
2022
Q1 		$4.43M Buy
178,921
+156,960
+715% +$4.75M ﹤0.01% 2404
2021
Q4 		$763K Buy
21,961
+21,563
+5,418% +$684K ﹤0.01% 2719
2021
Q3 		$11K Buy
398
+165
+71% +$4.19K ﹤0.01% 3580
2021
Q2 		$6K Sell
233
-7
-3% -$168 ﹤0.01% 3662
2021
Q1 		$5K Sell
240
-213,170
-100% -$5.38M ﹤0.01% 3528
2020
Q4 		$4.59M Sell
213,410
-104
-0% -$2.53K ﹤0.01% 2202
2020
Q3 		$3.15M Sell
213,514
-74,552
-26% -$1.35M ﹤0.01% 2193
2020
Q2 		$6.43M Buy
288,066
+90,838
+46% +$1.66M ﹤0.01% 1967
2020
Q1 		$2.79M Buy
197,228
+20,915
+12% +$317K ﹤0.01% 2110
2019
Q4 		$2.87M Sell
176,313
-3,880,826
-96% -$91.8M ﹤0.01% 2174
2019
Q3 		$142M Buy
4,057,139
+3,581
+0.1% +$170K 0.02% 751
2019
Q2 		$229M Buy
4,053,558
+5,571
+0.1% +$401K 0.03% 594
2019
Q1 		$296M Buy
4,047,987
+35,252
+0.9% +$2.43M 0.04% 495
2018
Q4 		$256M Buy
4,012,735
+77,268
+2% +$5.75M 0.04% 495
2018
Q3 		$393M Buy
3,935,467
+410,918
+12% +$34.1M 0.04% 410
2018
Q2 		$250M Sell
3,524,549
-46,051
-1% -$3.86M 0.03% 581
2018
Q1 		$372M Buy
3,570,600
+246,647
+7% +$27.8M 0.04% 430
2017
Q4 		$335M Buy
3,323,953
+1,131,923
+52% +$83.3M 0.04% 487
2017
Q3 		$76.6M Buy
+2,192,030
New +$59.1M 0.01% 1098

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Fidelity Investments's ANAB Position: Q1 2026 in Review

Fidelity Investments increased its AnaptysBio (ANAB) stake by 1,644% in Q1 2026, buying an estimated $24M and bringing the position to 472,704 shares worth $26.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1679.

Fidelity Investments first reported a position in ANAB in Q3 2017 and has held it in 35 quarters since. The position peaked at $393M in Q3 2018. 207 funds tracked by Wall St. Rank hold ANAB as of Q1 2026.

  • Fidelity Investments held 472,704 shares of AnaptysBio worth $26.2M as of Q1 2026.
  • Fidelity Investments bought 445,596 AnaptysBio shares in Q1 2026, an estimated $24M.
  • AnaptysBio made up ﹤0.01% of Fidelity Investments's portfolio in Q1 2026, its #1679 holding.
  • Fidelity Investments first reported a position in AnaptysBio in Q3 2017 and has held it in 35 quarters since.
  • Fidelity Investments's AnaptysBio position peaked at $393M in Q3 2018.
  • 207 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2026.

Based on Fidelity Investments's 13F filing for Q1 2026, filed 15 May 2026.